Literature DB >> 26269205

Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

T Robak1, E Matutes2, D Catovsky3, P L Zinzani4, C Buske5.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26269205     DOI: 10.1093/annonc/mdv200

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  21 in total

1.  Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.

Authors:  Dai Chihara; Hagop Kantarjian; Susan O'Brien; Jeffrey Jorgensen; Sherry Pierce; Stefan Faderl; Alessandra Ferrajoli; Rebecca Poku; Preetesh Jain; Phillip Thompson; Mark Brandt; Rajyalakshmi Luthra; Jan Burger; Michael Keating; Farhad Ravandi
Journal:  Br J Haematol       Date:  2016-06-15       Impact factor: 6.998

Review 2.  Moxetumomab Pasudotox: Clinical Experience in Relapsed/Refractory Hairy Cell Leukemia.

Authors:  Julie Feurtado; Robert J Kreitman
Journal:  Clin J Oncol Nurs       Date:  2019-06-01       Impact factor: 1.027

Review 3.  Advances in the Treatment of Hairy Cell Leukemia Variant.

Authors:  Julie Tran; Charles Gaulin; Martin S Tallman
Journal:  Curr Treat Options Oncol       Date:  2022-02-18

Review 4.  Hairy cell leukemia: Past, present and future.

Authors:  Bartlomiej M Getta; Jae H Park; Martin S Tallman
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-21       Impact factor: 3.020

5.  Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Oncologist       Date:  2019-10-18

6.  Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases.

Authors:  Andrea Visentin; Silvia Imbergamo; Federica Frezzato; Marco Pizzi; Roberta Bertorelle; Edoardo Scomazzon; Tamara Berno; Marcello Riva; Elisa Piva; Monica Facco; Francesco Piazza; Gianpietro Semenzato; Livio Trentin
Journal:  Oncotarget       Date:  2017-09-28

7.  An Unusual Giant Leg Ulcer as a Rare Presentation of Sweet's Syndrome in a Patient with Hairy Cell Leukemia Successfully Managed by Splenectomy.

Authors:  Hakan Özdoğu; Mahmut Yeral; Can Boğa
Journal:  Turk J Haematol       Date:  2017-03-08       Impact factor: 1.831

8.  Hairy cell leukemia: a case report of atypical presentation without splenomegaly.

Authors:  Mona Alfaraj; Hussain Alsaeed
Journal:  Blood Res       Date:  2017-06-22

Review 9.  Long-term follow-up after purine analogue therapy in hairy cell leukaemia.

Authors:  Monica Else; Claire E Dearden; Daniel Catovsky
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

10.  Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.

Authors:  Xavier Troussard; Edouard Cornet
Journal:  Am J Hematol       Date:  2017-12       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.